Rare
lephants
Screener
Toggle theme
MariMed Inc.
MRMD
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2017
Total Cash from Operations:
$10.0M
Line Item
Value
% of Total
Capital Expenditures
$1.2M
11.7%
Other Investing
$213.0K
2.1%
Other Financing
$4.7M
47.3%
Working Capital
$2.3M
22.8%
Net Cash Flow
$1.6M
16.1%
Download CSV
